pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·6h ago·1 min read
save

Anthropic’s Claude AI designs miniproteins from scratch in new study

Aug 19, 2026·read at Endpoints ↗Neutral

Anthropic announced that its AI system Claude was used to design and generate miniproteins from scratch in a recent research campaign.

The study showed Claude could propose novel protein sequences, creating a library of miniproteins without relying on existing templates.

Anthropic highlighted the potential of AI‑driven protein design for future life‑science applications, while noting that broader implications remain to be evaluated.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Analysis: What Anthropic's protein study says about its life-sciences aims”

read at Endpoints ↗
94 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoFor Moderna, cancer vaccine results ease investor skepticism on its future as stock soarsEndpoints
  • 3h agoFDA approves Regeneron’s garetosmab for disease that turns tissue to boneEndpoints
  • 3h agoFDA pick Heidi Overton has been critical of vaccine requirements, abortion pillsEndpoints
  • 7h agoAmylin design debate heats up as Lilly's crucial mid-stage weight loss data nearEndpoints
  • 7h agoAmgen cans its TScan partnership; Amylyx reveals $350M offeringEndpoints